Showing results 3 to 5 of 5
< previous
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Clinical efficacy and safety of pemetrexed with or without either Bevacizumab or Pembrolizumab in patients with metastatic nonsquamous non–small cell carcinoma Journal:Asia-Pacific Journal of Clinical Oncology | 2022 | ||
Serum protein level as a predictor of therapeutic response and adverse effects associated with afatinib use Journal:Journal of Thoracic Disease | 2022 | ||
| 2022 |